Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2020 | Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group | Andr? T.; Vernerey D.; Im S.A.; Bodoky G.; Buzzoni R.; Reingold S.; Rivera F.; McKendrick J.; Scheithauer W.; Ravit G.; Fountzilas G.; Yong W.P.; Isaacs R.; ?sterlund P.; JIN-TUNG LIANG ; Creemers G.J.; Rakez M.; Van Cutsem E.; Cunningham D.; Tabernero J.; de Gramont A. | Annals of Oncology | 19 | 18 | |
2012 | Safety analysis of FOLFOX4 treatment in colorectal cancer patients: A comparison between two Asian studies and four western studies | Sugihara K.; Ohtsu A.; Shimada Y.; Mizunuma N.; PO-HUANG LEE ; De Gramont A.; Goldberg R.M.; Rothenberg M.L.; Andr? T.; Brienza S.; Gomi K. | Clinical Colorectal Cancer | 21 | 20 |